As the digested carbohydrate, glucose, is mainly absorbed through apical GLUT2 in addition to SGLT1 and GLUT5 into small intestinal cells, inhibition of GLUT2 is a strategy for suppression of hyperglycemia in T2DM patients. This evidence concerns the gene SLC2A2 and Hyperglycemia.